Gordon Blackburn-Munro
Overview
Explore the profile of Gordon Blackburn-Munro including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
564
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rode F, Thomsen M, Brolos T, Jensen D, Blackburn-Munro G, Bjerrum O
Eur J Pharmacol
. 2007 Mar;
564(1-3):103-11.
PMID: 17383631
Neuropathic pain conditions can encompass a diverse constellation of signs and symptoms consisting of sensory deficits, allodynia and hyperalgesia. Animal models of neuropathic pain have enabled the identification of key...
2.
Pedersen L, Scheel-Kruger J, Blackburn-Munro G
Pain
. 2006 Sep;
127(1-2):17-26.
PMID: 16965855
The contribution of the amygdala to neuropathic pain processing in animals has not been clearly acknowledged. To assess the relative contribution of amygdala GABA-A receptors in mediating sensory-discriminative and affective-motivational...
3.
Rode F, Brolos T, Blackburn-Munro G, Bjerrum O
Psychopharmacology (Berl)
. 2006 Jun;
187(3):364-75.
PMID: 16783541
Rationale: Neuropathic pain is associated with a number of disease states of diverse aetiology that can share common pathophysiological mechanisms. Antiepileptic drugs modulate ion channel function and antidepressants increase extracellular...
4.
Pedersen L, Blackburn-Munro G
Psychopharmacology (Berl)
. 2006 Feb;
185(2):208-17.
PMID: 16479373
Rationale: Classical pain tests performed in animals routinely measure evoked nociceptive behaviours. These almost exclusively reflect sensory processing of nociceptive transmission, although a recently described place escape/avoidance paradigm may be...
5.
Pedersen L, Nielsen A, Blackburn-Munro G
Psychopharmacology (Berl)
. 2005 Sep;
182(4):551-61.
PMID: 16133135
Rationale: Neuropathic pain is characterised by hyperexcitability within nociceptive pathways that manifests behaviourally as allodynia and hyperalgesia and remains difficult to treat with standard analgesics. However, antidepressants have shown reasonable...
6.
Erichsen H, Hao J, Xu X, Blackburn-Munro G
Pain
. 2005 Jun;
116(3):347-358.
PMID: 15982817
Controversy persists in relation to the analgesic efficacy of opioids in neuropathic pain. In the present study the effects of acute, subcutaneous administration of the mu-opioid receptor agonists morphine, methadone...
7.
Rode F, Jensen D, Blackburn-Munro G, Bjerrum O
Eur J Pharmacol
. 2005 Jun;
516(2):131-8.
PMID: 15936014
Gamma aminobutyric acid (GABA) plays a major role in the central hyperexcitabilty associated with nerve damage. The precise antinociceptive actions mediated by GABA(A) receptor agonists remain unclear as previous studies...
8.
Bomholt S, Mikkelsen J, Blackburn-Munro G
Brain Res
. 2005 May;
1044(2):216-26.
PMID: 15885220
Chronic pain conditions such as rheumatoid arthritis and fibromyalgia are associated with profound hypothalamo-pituitary-adrenal (HPA) axis dysfunction which may exacerbate symptoms of chronic pain. HPA axis dysfunction has also been...
9.
Bomholt S, Mikkelsen J, Blackburn-Munro G
Neuropharmacology
. 2005 Feb;
48(2):252-63.
PMID: 15695164
The effects of acute, systemic administration of amitriptyline, duloxetine and mirtazapine (antidepressant drugs that variously affect extracellular noradrenaline and serotonin levels) and the selective serotonin reuptake inhibitor (SSRI) citalopram were...
10.
Blackburn-Munro G, Bomholt S, Erichsen H
Neuropharmacology
. 2004 Jul;
47(3):351-62.
PMID: 15275824
The effects of systemic administration of the novel AMPA/GluR5 selective receptor antagonist NS1209 in animal models of experimental pain have been tested and compared with the AMPA receptor antagonist NBQX...